Jane Liu, PhD, is Co-Founder and CEO of BRT Biotechnologies (https://brtbio.com), an early-stage biotechnology company providing chemistry solutions to drug discoverers in academia, biotech, and pharma companies. The mission of BRT is to accelerate drug discovery programs. BRT’s vision is to provide unique products (massive libraries of macrocycles) and quality services (hit follow-up support, support for lead optimization). BRT’s value is that the company provides 2-10x larger libraries of macrocycles for drug discovery programs, as well as follow-up support that can accelerate drug discovery 4x faster than current approaches.